Phase 1 Combination Template X. ADVERSE EVENTS: LIST AND REPORTING REQUIREMENTS Adverse event (AE) monitoring and reporting is a routine part of every clinical trial. The following list of AEs (Section X.1) and the ch - CTEP - Document - PDFSEARCH.IO

First Page	Meta Content
	Phase 1 Combination Template X. ADVERSE EVENTS: LIST AND REPORTING REQUIREMENTS Adverse event (AE) monitoring and reporting is a routine part of every clinical trial. The following list of AEs (Section X.1) and the ch Add to Reading List Document Date: 2008-05-28 21:39:37 Open Document File Size: 82,50 KB Share Result on Facebook Company AEs / Expedited AE / CTEP / / Event FDA Phase / / IndustryTerm chemotherapy protocols / Internet connectivity / / MedicalCondition progressive disease / birth defects / / MedicalTreatment chemotherapy / / Organization Lead Organization / / / Position Investigator / Coordinator / Principal Investigator / and the local treating physician / / Product Investigational / / Technology NCI-sponsored chemotherapy protocols / / URL http / SocialTag Pharmaceutical sciences Pharmaceutics Pharmacology Adverse event Food and Drug Administration Clinical trial Clinical research Pharmaceutical industry Research

Phase 1 Combination Template X. ADVERSE EVENTS: LIST AND REPORTING REQUIREMENTS Adverse event (AE) monitoring and reporting is a routine part of every clinical trial. The following list of AEs (Section X.1) and the chAdd to Reading List